COVID-19 Prompts Regulation Rollbacks, And 3 May Have Lasting Effects For Health Care

Nicole Fisher

At the beginning of 2017, the Trump Administration committed to reducing federal regulation and reining in regulatory costs. In fact, Executive Order 13771 was filed on January 20th, 2017 to do just that. Since that time, there has been a significant amount of deregulation across policy arenas such as the environment, labor, and health care. However, the SARS-CoV-2 coronavirus has infiltrated the legislative and regulatory world – just as it has every other facet of life.

In response, the administration has targeted a number of previous regulations for rollback. Thus, the Brookings Institution, a research group in Washington, D.C., has added a COVID-19 filter to its Deregulatory Tracker, a real-time tracking system for “delays, repeals, new rules, notable guidance, and policy revocations.” As of April 30th, the system has noted six COVID-related deregulations. Three are directly connected to the Centers for Medicare and Medicaid Services (CMS) and the Department of Health and Human Services (HHS). Three others are tied to accessing small business loans, the Federal Reserve, and environmental regulations.

Click here to read more of this Forbes article by Nicole Fisher.